BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4039593)

  • 41. Long lasting efficacy of Bezalip retard on the regulation of lipid levels after discontinuation of administration in patients with hyperlipoproteinemia.
    Császár A; Karádi I; Köszegi G; Pados G; Németh-Csóka M; Pichler M; Romics L
    Klin Wochenschr; 1990; 68 Suppl 22():96-8. PubMed ID: 2087089
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of dietary fish supplementation on lipoprotein levels in patients with hyperlipoproteinemia.
    Sucić M; Katica D; Kovacević V
    Coll Antropol; 1998 Jun; 22(1):77-83. PubMed ID: 10097422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pre- and post-treatment values of HDL cholesterol and total: HDL cholesterol ratio in hyperlipoproteinaemic subjects.
    Sale JK; Johnstone JH
    Ann Clin Biochem; 1981 Mar; 18 (Pt 2)():71-5. PubMed ID: 7259072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women.
    Merz-Demlow BE; Duncan AM; Wangen KE; Xu X; Carr TP; Phipps WR; Kurzer MS
    Am J Clin Nutr; 2000 Jun; 71(6):1462-9. PubMed ID: 10837286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The hypocholesterolemic effect of dietary soybean protein vs. casein in hamsters fed cholesterol-free or cholesterol-enriched semipurified diets.
    Terpstra AH; Holmes JC; Nicolosi RJ
    J Nutr; 1991 Jul; 121(7):944-7. PubMed ID: 2051236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meta-analysis of the effects of soy protein intake on serum lipids.
    Anderson JW; Johnstone BM; Cook-Newell ME
    N Engl J Med; 1995 Aug; 333(5):276-82. PubMed ID: 7596371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
    Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N
    Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Modification of serum lipoproteins by soy bean proteins].
    Richter WO; Weisweiler P; Schwandt P
    MMW Munch Med Wochenschr; 1981 Nov; 123(46):1755-6. PubMed ID: 6796844
    [No Abstract]   [Full Text] [Related]  

  • 49. Decreasing dietary lauric and myristic acids improves plasma lipids more favorably than decreasing dietary palmitic acid in rhesus monkeys fed AHA step 1 type diets.
    Khosla P; Hajri T; Pronczuk A; Hayes KC
    J Nutr; 1997 Mar; 127(3):525S-530S. PubMed ID: 9082040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intake of 25 g of soybean protein with or without soybean fiber alters plasma lipids in men with elevated cholesterol concentrations.
    Bakhit RM; Klein BP; Essex-Sorlie D; Ham JO; Erdman JW; Potter SM
    J Nutr; 1994 Feb; 124(2):213-22. PubMed ID: 8308570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dietary persimmon improves lipid metabolism in rats fed diets containing cholesterol.
    Gorinstein S; Bartnikowska E; Kulasek G; Zemser M; Trakhtenberg S
    J Nutr; 1998 Nov; 128(11):2023-7. PubMed ID: 9808659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of bezafibrate during 4.5 years of treatment of hyperlipoproteinaemia.
    Olsson AG; Lang PD; Vollmar J
    Atherosclerosis; 1985 May; 55(2):195-203. PubMed ID: 4004990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of a soy-based compared with a traditional low-calorie diet on weight loss and lipid levels in overweight adults.
    Liao FH; Shieh MJ; Yang SC; Lin SH; Chien YW
    Nutrition; 2007; 23(7-8):551-6. PubMed ID: 17574819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women.
    Wangen KE; Duncan AM; Xu X; Kurzer MS
    Am J Clin Nutr; 2001 Feb; 73(2):225-31. PubMed ID: 11157317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ; Brun D; Gagné C; Moorjani S; Bielman P; Julien P
    Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in plasma lipid and lipoprotein fractions after alteration in dietary cholesterol, polyunsaturated, saturated, and total fat in free-living normal and hypercholesterolemic children.
    Stein EA; Shapero J; McNerney C; Glueck CJ; Tracy T; Gartside P
    Am J Clin Nutr; 1982 Jun; 35(6):1375-90. PubMed ID: 7081119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects.
    Ferlito S; Ricceri M; Ossino AM
    Int Angiol; 1989; 8(3):140-4. PubMed ID: 2592796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the efficacy and tolerance of a garlic preparation vs. bezafibrate.
    Holzgartner H; Schmidt U; Kuhn U
    Arzneimittelforschung; 1992 Dec; 42(12):1473-7. PubMed ID: 1288512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The hypolipidemic effect of locust bean gum food products in familial hypercholesterolemic adults and children.
    Zavoral JH; Hannan P; Fields DJ; Hanson MN; Frantz ID; Kuba K; Elmer P; Jacobs DR
    Am J Clin Nutr; 1983 Aug; 38(2):285-94. PubMed ID: 6308996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.